Proof-of-Concept Phase 2a Trial of VH4524184 (VH-184), an Emerging Third-Generation Integrase Strand Transfer Inhibitor With an Enhanced Resistance Profile. (academic.oup.com)

Authors: Rogg L … Gartland M Journal: Clinical Infectious Diseases Published: 2026-06-12 DOI: https://doi.org/10.1093/cid/ciag357